RPRX compared with RYAAY: revenue, margins and what each company keeps, and the suppliers and customers both name

RPRXRoyalty Pharma plc

Mkt capRevenueRevenue

RYAAYRyanair Holdings PLC

Mkt capRevenueRevenue

Compare

RPRXRoyalty Pharma plc

RYAAYRyanair Holdings PLC

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

RYAAY: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only RPRX 8

BIIBBiogencustomer

EXELExelixiscustomer

DNLIDenali Therapeuticssupplier

SNDXSyndax Pharmaceuticalssupplier

4 more · RPRX chain ›

Shared 0

No disclosed counterparties: RYAAY.

Only RYAAY 0

None

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

RPRX, solidRYAAY, dashed

RPRXRoyalty Pharma plc

67.19▲+1.91%· post 67.34

Mkt cap$38.6BRevenue$674MQ2 FY26Revenue$2.4BFY25

RYAAYRyanair Holdings PLC

53.67▲+0.52%· post 53.66

ClosedOct 30 '26

Mkt cap$11.2BRevenue—Revenue—

Compare

ClosedOct 30 '26

RPRXRoyalty Pharma plc

RYAAYRyanair Holdings PLC

67.19▲+1.91%post 67.34

Price

53.67▲+0.52%post 53.66

$38.6B

Mkt cap

$11.2B

Q2 FY26$674M

Revenue

—

FY25$2.4B

Revenue

—

RPRX67.19▲+1.91%vsRYAAY53.67▲+0.52%ClosedOct 30 '26